« Previous
Next »
Journal of Vascular Surgery
Volume 47, Issue 6
, Pages
1227-1234
, June 2008
Staged bilateral carotid stenting, an effective strategy in high-risk patients – insights from a prospective multicenter trial
-
Kaplan-Meier analysis of primary endpoint. Cumulative freedom from major adverse events did not differ between patients from the pivotal and from the bilateral group (P = .5479 by log-rank).
Kaplan-Meier analysis of primary endpoint. Cumulative freedom from major adverse events did not differ between patients from the pivotal and from the bilateral group (P = .5479 by log-rank).
The BEACH trial was supported by Boston Scientific Corporation.
Competition of interest: Drs Iyer, Hopkins, and Katzen are consultants of Boston Scientific Corporation (BSC); Dr Kelley is former employee of BSC; Drs Iyer, Hopkins, and Katzen are stockholders of BSC; Drs Hopkins and Katzen receive educational grant support from BSC; Drs White and Diehm have no conflicts to report related to this trial.
PII: S0741-5214(08)00107-9
doi: 10.1016/j.jvs.2008.01.035
© 2008 The Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 47, Issue 6
, Pages
1227-1234
, June 2008
